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1.56-fold compared with cells treated with H2O2 alone after 24-hour incubation
(P<0.01). Meanwhile, PAI-1 protein expression decreased in the 20mM Rb1-
pretreated cells by 1.39-fold compared to that in cells treated with H2O2 alone (P<0.01).
Conclusions: Our report demonstrates that Rb1 can exert protective effects on H2O2-
induced cellular injury through modulating PAI-1 expression.
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Objectives: Cardiac apoptosis plays an important role in the pathology of myocar-
dial infarction. The protective effects of Dipeptidyl peptidase (DPP) -4 inhibitor
(vildagliptin) on cardiac apoptosis were evaluated in isoproterenol induced myocardial
infarcted rats.
Methods: Male Wistar rats are treated intravenously with Vildagliptin (2 mg/kg/day)
daily for a period of 21 days. After 21 days of pretreatment, isoproterenol (100 mg/kg)
was injected subcutaneously to rats at an interval of 24 h for 2 days (on 22th and 23th
day) to induce myocardial infarction. Cardiac diagnostic markers, heart lipid peroxi-
dation, antioxidant system, histopathological changes of the heart and apoptosis were
evaluated in isoproterenol induced myocardial infarcted rats.
Results: Isoproterenol induced myocardial infarcted rats showed a signiﬁcant increase
in the levels of serum cardiac diagnostic markers, heart lipid peroxidation products and a
signiﬁcant decrease in the activities/levels of heart antioxidants, compared with normal
rats. Additionally, Histopathological ﬁndings of myocardial infarcted rats revealed
marked necrosis. Real Time Polymerase Chain Reaction study revealed an increase in
the myocardial expression of Bax, caspase-8, caspase-9 and Fas genes and a decrease in
the myocardial expression of Bcl-2 and Bcl-xL genes.Vildagliptin (2 mg/kg/day) pre-
treatment decreased the levels of serum cardiac marker enzymes, reduced heart lipid
peroxidation and minimized the alterations the activities/levels of heart antioxidants of
isoproterenol-induced myocardial infarcted rats. Histopathological study evidenced that
the pretreatment with Vildagliptin inhibited myocardial damage. Vildagliptin pre-
treatment also showed protective effects on apoptosis. The in vitro study also revealed
the free radical scavenging and anti-apoptosis activity of Vildagliptin.
Conclusions: Thus, Vildagliptin protected the myocardial infarcted rat’s heart against
apoptosis by inhibiting oxidative stress.
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Objectives: The interactional relationship between the sympathetic nervous systems
(SNS) and the renin-angiotensin-aldosterone system (RAS) has been revealed but
poorly investigated. The present work was designed to explore the effect of meto-
prolol (MET) treatment on the RAS, especially the expression and vasomotor function
of AT2R, in spontaneously hypertensive rats (SHR).
Methods: SHR was treated with metoprolol for 4 weeks. The dynamic changes of the
blood pressure, renin activity, Ang II concentration and AT2R expression were
investigated. Superior mesenteric resistance arteries were isolated for determining the
protein expression of AT1R and AT2R. Perfusion experiment was carried out to
explore the vasomotor function of AT2R.
Results: The results showed that up-regulated renin activity and Ang II concentration
of plasma in SHR were inhibited by metoprolol treatment. In isolated superior
mesenteric arteries from both WKY and SHR, Ang II perfusion induced vasodilatation
after AT1R inhibition by telmisartan, although the vasodilatation was harmed in SHR.
Furthermore, AT2R inhibitor PD123319 arrested the vasodilatation induced by Ang
II. SHR received metoprolol exerted improved vasodilatation mediated by AT2R
(47.295.16% versus 24.994.93% for MET and SHR, respectively, P<0.05).
Western blot analysis showed that metoprolol restored expression of AT2R in SHR,
which may contribute to metoprolol’s antihypertensive effect.
Conclusions: These results suggested an impact of b-adrenergic blocker on RAS and
supported an important role of AT2R in antihypertensive treatment.
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Objectives: Secreted frizzled-related protein 5 (Sfrp5) has been described as novel
adipokine with anti-inﬂammatory properties at present. However, it’s expression and
protection mechanisms in the cardiomyocyte hypertrophy at the cellular level are not
thoroughly understood. Here, the authors report for the ﬁrst time by means of
angiotensin II induced cardiomyocyte hypertrophy in vitro that the expression and
mechanisms of Sfrp5.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BMethods: Cardiomyocytes were preincubated with Ang II through primary culture of
cardiac cells of neonatal SD rats. Telmisartan and PD123319 were used to block Ang
II type-1 and type-1 receptors respectively. Rho proteins have been suggested as major
contributors to cardiac hypertrophy. Here, inhibition of the Rho/ROCK pathway by
Y-27632, a selective inhibitor of ROCK, we determined the hypothesis that Rho and
Rho-associated kinase (Rho/ROCK) as mediators of the expression of sFRP5 in
angiotensin II (Ang II) -induced cardiomyocyte hypertrophy. Reverse transcription-
polymerase chain reaction and Western blot were used to estimate the expression of
sfRP5, brain natriuretic peptide (BNP) and phosphorylation of MYPT-1.
Results: sFRP5 was discovered expressed in cardiomyocytes. Ang II treatment
induced the increased expression of sFRP5 and BNP in a dose-and time-dependent
manner in cardiomyocytes, after preincubating with AT1-R antagonist telmisartan
completely blocked Ang II-induced sFRP5 expression increasement. The recession of
phosphorylation of MYPT-1 (P-MYPT 1) and sFRP5 were expressed after inhibiting
of Rho/ROCK.
Conclusions: The increased sFRP5 expression was mainly through the AT1-R-Rho/
ROCK signal pathway in the process of Ang IIinduced cardiomyocyte hypertrophy.
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Objectives: To investigate the effect of knockdown of b1-AR in myocardium on
metoprolol antihypertension of SHRs.
Methods: (1) Construct pAAV-ZsGreen-ADRB1-shRNA plasmid; pAAV-ZsGreen-
ADRB1-shRNA plasmid was constructed according to shRNA principle and b1-AR
coding sequence in Genebank. Conﬁrmed by enzyme digestion and gene sequencing,
showing that 100% identical to its accession number. The plasmid was then packaged
to recombinant adeno-associated virus named AAV9- shRNA-ADRB1-ZsGreen and
harvested (viral titer was 1.5x1012vg/ml). (2) Spontaneousely Hypertensive Rats
treatments; 36 SHRs were grouped into six randomly as follows:Group 1, AAV9-
shRNA-ADRB1-ZsGreen + metoprolol (n¼6); Group2, AAV9-shRNA-ADRB1-
ZsGreen+saline (n¼6); Group 3, AAV9-CMV-ADRB1- ZsGreen + metoprolol
(n¼6); Group 4, AAV9-CMV-ADRB1-ZsGreen + saline Group (n¼6); Group 5,
sham + metoprolol Group (n¼6); Group 6, sham + saline (n¼6). Metoprolol were
given by gavage in 50mg/kg/d dose. All of them were monitored their blood pressure
weekly. Rats were killed and dissected the myocardial tissue after 4 weeks. (3) The
research on the expression of b1-AR in myocardial tissue among all rats groups in
transcription and translation levels, Real-time RT-PCR, Immunohistochemistry and
Western blot were used to assay the expression of b1-AR gene.
Results: (1) Comparison of the b1-AR expression among each group: Real-time
RT-PCR results showed that AAV9-shRNA-ADRB1-ZsGreen injection could
signiﬁcantly decrease b1-AR mRNA expression compared with the negative control
group (P <0.05) Immunohistochemistry results showed that it could signiﬁcantly
decrease theb1-AR protein expression compared with the negative control and sham
group (P <0.05 ), Western blot results showed that it also could signiﬁcantly decrease
the b1-AR protein expression compared with the negative control group (P <0.05).
(2) Comparison of the antihypertensive effects among each group: After 4 weeks of
the intervention, systolic blood pressure in group 1, group 2, group 3, group 5 was
signiﬁcantly lower than group 4 and group 6 (P<0.05); After 4 weeks of metoprolol
intervention, the SBP drop pressure amplitude of AAV9-shRNA-ADRB1-ZsGreen
injection group were signiﬁcantly lower than the negative control group and the sham
group (22.841.72 vs.28.782.72 vs.30.165.71, P<0.05).
Conclusions: (1) The AAV9-shRNA-ADRB1-ZsGreen is successfully constructed
and it can signiﬁcantly reduce the b1-AR expression in myocardial of SHRs. (2)
Knockdown of b1-AR in myocardial tissue of Spontaneousely Hypertensive Rats
resulted in worse antihypertensive response to metoprolol; it may be one of the rea-
sons for inﬂuencing individual antihypertensive response to metoprolol.
GW25-e4377
Expression of ZO-1 in iPS cells Mediated by Lentiviral Vector
Sheng Tao1, Li Hui2, Sun Zhi-Shan2, Zeng Jian-Ping2
1The Second Xiangya Hospital of Central South University, 2Xiangtan Central
Hospital
Objective: The fundamental researches of cardiovascular disease veriﬁed that inter-
calated disc-related gene ZO-1varis in different myocardial pathologic conditions, and
it interacts with Cx43. This research is about to construct recombinant lentivirus
over-expressing vector of porcine ZO-1 gene, to infect iPS cells, to obtain iPS cells
carrying this target gene.
Methods: The ZO-1gene sequence publicated on Gendbank was analyzed, and
designed a couple of primer containing both BamHI and SalI. The porcine ZO-1 gene
was ampliﬁed by PCR, and cloned into lentiviral expression vector, to construct the
recombinant Lenti-EF1a-EGFP-TRE-ZO1 vector; the vector was conﬁrmed by DNA
sequencing. The production of lentivirus was obtained by using pVSVG, delta
8.91and fugene to contransfect 293T cells. The titer of lentivirus was testd with
ﬂuorescent expression, to infect iPS cells.asic and Translational Medicine C43
